A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents
Phase 2
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000004026
- Lead Sponsor
- Digestive Disease Center, Showa University Nothern Yokohama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Synchronous or metachronous malignancy. 2)Pregnant women. 3)Breast-feeding women. 4)Active or chronic viral hepatitis. 5)Active bacterial or fungous infection. 6)Diabetes mellitus. 7)Systemic administration of corticosteroids. 8)Unstable hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method